首页> 外国专利> MiRNAs as novel therapeutic targets and diagnostic biomarkers for parkinsons disease

MiRNAs as novel therapeutic targets and diagnostic biomarkers for parkinsons disease

机译:MiRNA作为帕金森病的新型治疗靶标和诊断生物标志物

摘要

The disclosure provides pharmaceutical compositions including an oligonucleotide that down-regulates the over-expression of at least one miRNA of SEQ ID NOs: 1-283. The oligonucleotide may be complementary to the nucleotide sequence of at least one of SEQ ID NOs: 1-283, or hybridizes under stringent conditions to a nucleotide sequence of at least one of SEQ ID NOs: 1-283. Further provided are methods of diagnosing Parkinson's Disease (PD) in a subject. The methods may include detecting the level of expression of at least one miRNA of SEQ ID NOs: 1-283 in a biological sample from the subject, and comparing the level of expression in the sample to the level of expression in a reference. Further provided are methods for treating, preventing, or reducing the risk of PD. Kits are also provided.
机译:本公开提供了药物组合物,其包含下调SEQ ID NO:1-283的至少一种miRNA的过表达的寡核苷酸。寡核苷酸可以与SEQ ID NO:1-283中的至少一个的核苷酸序列互补,或在严格条件下与SEQ ID NO:1-283中的至少一个的核苷酸序列杂交。还提供了诊断受试者的帕金森氏病(PD)的方法。所述方法可包括检测来自受试者的生物样品中的至少一种SEQ ID NO:1-283的miRNA的表达水平,并将样品中的表达水平与参照中的表达水平进行比较。还提供了用于治疗,预防或降低PD风险的方法。还提供了套件。

著录项

  • 公开/公告号US9540692B2

    专利类型

  • 公开/公告日2017-01-10

    原文格式PDF

  • 申请/专利权人 RUSH UNIVERSITY MEDICAL CENTER;

    申请/专利号US201314416932

  • 发明设计人 SHUNBIN XU;

    申请日2013-07-24

  • 分类号C12Q1/68;C07H21/02;C07H21/04;C12N15/113;

  • 国家 US

  • 入库时间 2022-08-21 13:41:17

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号